Graduate School of health and Medical Sciences

Cancer Immunology and Immunotherapy
Provider: Faculty of Health and Medical Sciences

Activity no.: 3686-23-00-00
	Enrollment deadline: 16/06/2023

Date and time	11.09.2023, at: 09:00 - 22.09.2023, at: 16:00
Regular seats	30
Course fee	5,040.00 kr.
Lecturers	Marco Donia
ECTS credits	2.80

Contact person	Mette W. Yde E-mail address: mette.wassard.yde@regionh.dk

Enrolment Handling/Course Organiser	PhD administration E-mail address: phdkursus@sund.ku.dk

Aim and content This course is free of charge for PhD students at Danish universities (except Copenhagen Business School), and for PhD Students from NorDoc member universities. All other participants must pay the course fee. Anyone can apply for the course, but if you are not a PhD student at a Danish university, you will be placed on the waiting list until enrollment deadline. This also applies to PhD students from NorDoc member universities. After the enrollment deadline, available seats will be allocated to applicants on the waiting list. Learning objectives A student who has met the objectives of the course will be able to: 1. Understand how the human immune system interact and shape the phenotype of cancer 2. Gain in depth knowledge on the methodologies used to study the immune response to cancer 3. Understand how cancer immunotherapies work in the clinical setting 4. Critically evaluate novel therapeutic approaches using the immune system to combat cancer Content This course cover all the main aspect of cancer immunology and immunotherapy, from the bench to the bedside. The focus of the course shifts between day 1-2, where basic and translational research are the main topics, to day 3 where the application of this knowledge in the clinic is presented. In day 1-2, selected aspects of the generation of immune response to cancer, avoidance of immune destruction, immune targets on cancer cells as well as how to evaluate immune response to cancer and use this knowledge to develop novel treatments will be discussed by active researchers in the field. Day 3 is mainly dedicated to the application of cancer immunotherapy in the clinical arena to cover both clinical research and real-wold application of cancer immunotherapies in western health systems. Day 4 is dedicated to international expert talks on topics discussed in day 1-3. Participants The course is relevant for PhD students who work on cancer or immunology related PhD projects, and aim to broaden their knowledge on basic, translational and clinical aspects of cancer immunology research. As such, PhD students engaged in basic, applied, and clinical cancer research projects are all welcome. Relevance to graduate programmes The course is relevant to PhD students from the following graduate programmes at the Graduate School of Health and Medical Sciences, UCPH: - Clinical Cancer Research - Immunology and Infectious Diseases - Cellular and Genetic Medicine Language English Form Lectures Program Please see the program here Course director Marco Donia, MD, PhD, Clinical Associate Professor, CCIT-DK, Herlev Hospital. marco.donia@regionh.dk Teachers Marco Donia Clinical Associate Professor, National Center for Cancer Immune Therapy, Herlev Alfredo Addeo, Professor, Geneva University Hospital; Switzerland Per Thor Straten, Professor, CCIT-DK, Herlev Hospital Mads Hald Andersen, Professor, CCIT-DK, Herlev Hospital Niels Behrendt Professor, University of Copenhagen Lars Rønn Olsen, PhD, Associate Professor, Technical University of Denmark Daniel Hargbøl Madsen M.Sc., PhD, Head of Animal Facility, National Center for Cancer Immune Therapy Özcan Met M.Sc., PhD, Head of Cell Therapy Unit, National Center for Cancer Immune Therapy Inge Marie Svane Professor, MD, co-director, National Center for Cancer Immune Therapy, Herlev Troels Holz Borch MD, PhD, National Center for Cancer Immune Therapy, Herlev Merete Schmiegelow M.Sc., Chairman of the Danish Melanoma Patient Association Morten Holmström MD, PhD, National Center for Cancer Immune Therapy, Herlev Eva Ellebæk MD, PhD, National Center for Cancer Immune Therapy, Herlev Cecile Gouttefangeas Professor, Department of Immunology, Tübingen, Germany Gitte Holmen Olofsson M.Sc., PhD, National Center for Cancer Immune Therapy, Herlev Mikkel Wandahl Pedersen PhD, Chief Scientific Officer, Nykode Therapeutics Vinay Prasad Professor, University of California, San Francisco; CA, USA Dates September 11-12, and September 21-22, 2023 All days 9-16. Course location Herlev Medborgerhus, Herlevgårdsvej 18-20, 2730 Herlev (Monday and Tuesday 11-12 September 2023 + Thursday 21 September). Herlev Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev Lille Auditorium (Friday 22 September 2023). Registration Please register before June 16th, 2023 Seats to PhD students from other Danish universities will be allocated on a first-come, first-served basis and according to the applicable rules. Applications from other participants will be considered after the last day of enrolment. Note: All applicants are asked to submit invoice details in case of no-show, late cancellation or obligation to pay the course fee (typically non-PhD students). If you are a PhD student, your participation in the course must be in agreement with your principal supervisor.

Click the search button to search Courses.

See which courses you can attend and when

Jan	Feb	Mar	Apr
May	Jun	Jul	Aug
Sep	Oct	Nov	Dec

New courses
Courses are published regularly. High demand courses are announced in spring and autumn.

Learn which courses are announced on fixed dates